Showing 2191-2200 of 20409 results for "".
New Research Suggests Increased Number of IVF Cycles Can Be Beneficial
https://reachmd.com/programs/the-jama-report/new-research-suggests-increased-number-ivf-cycles-can-be-beneficial/7864/[Read the Article] Women facing infertility often turn to in vitro fertilization (IVF). Although IVF technology has improved, there is still a widely held belief that if a woman doesn't experience a successful live birth after three or four IVF cycles, her chances of a successful live birth are veryProteinuria in CKD Progression: Understanding Its Role and Monitoring Strategies
https://reachmd.com/programs/clinicians-roundtable/proteinuria-in-ckd-progression-understanding-its-role-and-monitoring-strategies/37216/Not only can proteinuria be a predictor of chronic kidney disease (CKD) progression, but it can also contribute to that progression and kidney damage. That’s why it’s imperative that we monitor proteinuria levels in our patients and take the appropriate steps to reduce it. To learn more about proteiEarly Antibiotic Use May Halt Progression of Severe Respiratory Illness in Young Children
https://reachmd.com/programs/the-jama-report/early-antibiotic-use-may-halt-progression-severe-respiratory-illness-young-children/7768/[Read the Article] Preschool children who experience repeated episodes of severe lower respiratory tract infections (LRTI) often present with symptoms like wheezing and difficulty breathing. A new study looked at whether the use of the common antibiotic, azithromycin, would help prevent progressionDeciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
https://reachmd.com/programs/clinicians-roundtable/deciphering-the-link-proteinuria-and-egfr-dynamics-in-igan-and-fsgs/37215/High levels of proteinuria are associated with a high risk of kidney failure in the future, both for IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). In fact, proteinuria levels can help predict disease progression, outcomes, and even optimal therapeutic approaches. Joining Dr.Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice
https://reachmd.com/programs/project-oncology/modernizing-pulmonary-assessment-reassessing-race-neutral-interpretation-in-practice/39036/As medicine shifts toward race-neutral lung function interpretation, new challenges emerge in ensuring equitable access to care. Dr. Ajay Sheshadri explores how race-neutral spirometry may impact patient selection for lung resection surgery and hematopoietic cell transplantation. Dr. SheshadrDiagnosing and Treating Primary Biliary Cholangitis: Key Clinical Insights
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-primary-biliary-cholangitis-key-clinical-insights/29157/Tune in to learn how we can improve the diagnosis and treatment of primary biliary cholangitis.The Future of Psoriasis Care: Novel Therapies and Earlier Intervention
https://reachmd.com/programs/dermconsult/future-psoriasis-care-novel-therapies/39690/The psoriasis treatment landscape continues to evolve with new therapeutic targets, novel oral agents, and extended half-life biologics designed to enhance efficacy, convenience, and long-term outcomes. In this episode, Dr. James Song discusses emerging data on early intervention, the potential impaInsights on Migraine Care Disparities from OVERCOME
https://reachmd.com/programs/Audioabstracts/smigraine-care-disparities-overcome/49215/Socioeconomic factors like household income and insurance status can significantly influence access to migraine care, specialty treatment, and guideline-recommended therapies. Tune in to hear Ryan Quigley share findings from the OVERCOME study and explore how disparities in healthcare access may impAdvancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
https://reachmd.com/programs/project-oncology/advancing-cancer-care-key-considerations-for-subcutaneous-immunotherapies/32995/Subcutaneous cancer immunotherapies may offer a faster, more resource-efficient alternative to intravenous administration, improving patient convenience and accessibility while maintaining efficacy. However, careful monitoring for immunotherapy-related toxicities remains essential. Joining Dr. CharlHow Advances in Immunology Are Shaping CSU Care
https://reachmd.com/programs/clinicians-roundtable/how-advances-in-immunology-are-shaping-csu-care/56724/Chronic spontaneous urticaria (CSU) involves distinct immune mechanisms that set it apart from other inflammatory skin diseases, and advances in our understanding of cytokines and mast cell activation are reshaping how clinicians approach its diagnosis and treatment. Joining Dr. Steve Jackson to exp